Skip to Content

Grown Rogue International Inc GRUSF

Morningstar Rating
$0.70 −0.10 (12.50%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

GRUSF is trading within a range we consider fairly valued.
Price
$0.80
Fair Value
$9.56
Uncertainty
Very High
1-Star Price
$2.74
5-Star Price
$1.55
Economic Moat
Dksl
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if GRUSF is a good fit for your portfolio.

Trading Information

Previous Close Price
$0.80
Day Range
$0.680.80
52-Week Range
$0.120.90
Bid/Ask
$0.68 / $0.79
Market Cap
$145.78 Mil
Volume/Avg
216,788 / 224,112

Key Statistics

Price/Earnings (Normalized)
44.18
Price/Sales
5.92
Dividend Yield (Trailing)
Dividend Yield (Forward)
Total Yield

Company Profile

Grown Rogue International Inc is engaged in the business of growing and selling cannabis products. Its primary cannabis product produced and sold is cannabis flower. Geographically, the company generates a majority of its revenue from the United States.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Stock Style Box
Small Growth
Total Number of Employees
138

Valuation

Metric
GRUSF
Price/Earnings (Normalized)
44.18
Price/Book Value
12.59
Price/Sales
5.92
Price/Cash Flow
21.57
Price/Earnings
GRUSF

Financial Strength

Metric
GRUSF
Quick Ratio
0.72
Current Ratio
1.33
Interest Coverage
0.79
Quick Ratio
GRUSF

Profitability

Metric
GRUSF
Return on Assets (Normalized)
14.19%
Return on Equity (Normalized)
32.77%
Return on Invested Capital (Normalized)
24.94%
Return on Assets
GRUSF
See how this stock stacks up to its competitors with Morningstar Investor

Drug Manufacturers - Specialty & Generic Industry Comparables

Ticker
Name
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
MKKGY
Merck KGaA ADRSbjkbczqnVfhqcpn$78.9 Bil
ZTS
Zoetis Inc Class AMytytrcngBfm$77.6 Bil
HLN
Haleon PLC ADRMqcympjPfvg$37.6 Bil
TEVA
Teva Pharmaceutical Industries Ltd ADRDtyrjnhzySctvz$18.8 Bil
VTRS
Viatris IncXpyjmlsydZzm$12.4 Bil
RDY
Dr Reddy's Laboratories Ltd ADRJrwcgmckNrddx$11.8 Bil
CTLT
Catalent IncKkghtjtkkWrxmsvw$9.9 Bil
PRGO
Perrigo Co PLCJpjgbnsHpw$3.8 Bil
CURLF
Curaleaf Holdings IncPpcjyjxzFfjw$3.4 Bil
PBH
Prestige Consumer Healthcare IncTpfrjkkfLmxdky$3.2 Bil

Sponsor Center